13FPulse 13FPulse
中
More

Explore

Research

AB

ABBV ABBVIE INC

2026Q2 · CUSIP 00287Y109 · Big Pharma · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
4,202
Institutions that reported holding it to the SEC
Net increase in holders
+126
Last quarter 4,076 → now 4,202
How unusual is that
Top 5%
Stronger buying than 98% of US stocks
What the filings say, in one paragraph

4,202 funds held ABBV at the end of 2026Q2, up 126 from the quarter before. That is stronger buying than 98.2% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $64.4B(YoY +10.4%), the P/E is 81.0x. ABBV has had 31 buying rushes in its history, and the price moved +10.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector, tagged Big Pharma.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=1153 2013Q4: holders=1274 2014Q1: holders=1278 2014Q2: holders=1316 2014Q3: holders=1367 2014Q4: holders=1464 2015Q1: holders=1472 2015Q2: holders=1516 2015Q3: holders=1478 2015Q4: holders=1504 2016Q1: holders=1512 2016Q2: holders=1514 2016Q3: holders=1538 2016Q4: holders=1582 2017Q1: holders=1627 2017Q2: holders=1656 2017Q3: holders=1688 2017Q4: holders=1889 2018Q1: holders=1909 2018Q2: holders=1885 2018Q3: holders=1853 2018Q4: holders=1954 2019Q1: holders=1931 2019Q2: holders=1920 2019Q3: holders=1916 2019Q4: holders=2144 2020Q1: holders=2131 2020Q2: holders=2312 2020Q3: holders=2273 2020Q4: holders=2501 2021Q1: holders=2512 2021Q2: holders=2572 2021Q3: holders=2562 2021Q4: holders=2894 2022Q1: holders=2952 2022Q2: holders=2926 2022Q3: holders=2885 2022Q4: holders=3088 2023Q1: holders=3071 2023Q2: holders=3011 2023Q3: holders=3045 2023Q4: holders=3265 2024Q1: holders=3318 2024Q2: holders=3310 2024Q3: holders=3443 2024Q4: holders=3692 2025Q1: holders=3761 2025Q2: holders=3728 2025Q3: holders=3857 2025Q4: holders=4124 2026Q1: holders=4076 2026Q2: holders=4202 -332 -166 +0 +166 +332 103727254413 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 31 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 5% — —
2025Q4 Top 1% in the market -4.6% +19.9%
2025Q3 Top 1% in the market -3.4% -7.8%
2025Q1 Top 5% +12.0% +28.0%
2024Q4 Top 1% in the market -3.7% +9.0%
2024Q3 Top 1% in the market +22.7% +11.8%
2024Q1 Top 5% +19.4% +0.9%
2023Q4 Top 1% in the market -5.4% +13.0%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
405
Change in large funds
+45
Total value they hold
$357.4B
Funds buying for the first time
295
Funds that sold out entirely
169
Price change that quarter
+20.4%
Funds holding puts (bearish)
55
Funds holding calls (bullish)
57

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

Fundamentals

PE (TTM)
81.0
EPS (TTM)
$3.54
EPS YoY
+68.6%
Revenue (TTM)
$64.4B
Revenue YoY
+10.4%
Net margin
9.8%
ROE
—
Debt ratio
104.4%
FCF (TTM)
$18.2B
Dividend (TTM)
$6.83
Quarterly Revenue & EPS
2021-09-30: EPS 1.78 2021-12-31: EPS 2.26 2022-03-31: EPS 2.51 2022-06-30: EPS 0.51 2022-09-30: EPS 2.21 2022-12-31: EPS 1.38 2023-03-31: EPS 0.13 2023-06-30: EPS 1.14 2023-09-30: EPS 1.00 2023-12-31: EPS 0.46 2024-03-31: EPS 0.77 2024-06-30: EPS 0.77 2024-09-30: EPS 0.88 2024-12-31: EPS -0.02 2025-03-31: EPS 0.72 2025-06-30: EPS 0.52 2025-09-30: EPS 0.10 2025-12-31: EPS 1.02 2026-03-31: EPS 0.39 2026-06-30: EPS 2.03 0B 8.5B 17.0B $B -0.02 1.37 2.76 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 60 16 98 181 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
0K3.9B7.7B 20162017201820192020202120222023202420252026
Latest quarter $3.6B (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.